McCarroll SA, Feng G, Hyman SE. Genome-scale neurogenetics: methodology and meaning. Nat Neurosci. 2014;17(6):756-63. doi:10.1038/nn.3716
Strazisar M, Cammaerts S, Ven K, et al. MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol Psychiatry. 2015;20(4):472-81. doi:10.1038/mp.2014.53
Hyman SE. The unconscionable gap between what we know and what we do. Sci Transl Med. 2014;6(253):253cm9. doi:10.1126/scitranslmed.3010312
Brand H, Pillalamarri V, Collins RL, et al. Cryptic and complex chromosomal aberrations in early-onset neuropsychiatric disorders. Am J Hum Genet. 2014;95(4):454-61. doi:10.1016/j.ajhg.2014.09.005
Yoshimizu T, Pan JQ, Mungenast AE, et al. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol Psychiatry. 2015;20(2):162-9. doi:10.1038/mp.2014.143
Haesemeyer M, Schier AF. The study of psychiatric disease genes and drugs in zebrafish. Curr Opin Neurobiol. 2015;30:122-30. doi:10.1016/j.conb.2014.12.002
Hyman SE. Enlisting hESCs to Interrogate Genetic Variants Associated with Neuropsychiatric Disorders. Cell Stem Cell. 2015;17(3):253-4. doi:10.1016/j.stem.2015.08.013
Kaiser T, Feng G. Modeling psychiatric disorders for developing effective treatments. Nat Med. 2015;21(9):979-88. doi:10.1038/nm.3935
Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387(10028):1672-85. doi:10.1016/S0140-6736(15)00390-6
Duncan LE, Pollastri AR, Smoller JW. Mind the gap: why many geneticists and psychological scientists have discrepant views about gene-environment interaction (G×E) research. Am Psychol. 2014;69(3):249-68. doi:10.1037/a0036320